Literature DB >> 15221794

The CHEK2 c.1100delC mutation plays an irrelevant role in breast cancer predisposition in Italy.

Maria Adelaide Caligo, Simona Agata, Gitana Aceto, Rosella Crucianelli, Siranoush Manoukian, Bernard Peissel, Maria Chiara Scaini, Elisa Sensi, Serena Veschi, Alessandro Cama, Paolo Radice, Alessandra Viel, Emma D'Andrea, Marco Montagna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15221794     DOI： 10.1002/humu.20051

Source DB:  PubMed          Journal:  Hum Mutat        ISSN： 1059-7794            Impact factor:   4.878


× No keyword cloud information.
  13 in total

1.  CHEK2 c.1100delC mutation among non-BRCA1/2 Spanish hereditary breast cancer families.

Authors:  L Fachal; M Santamariña; A Blanco; A Carracedo; A Vega
Journal:  Clin Transl Oncol       Date:  2012-11-13       Impact factor: 3.405

Review 2.  The Epidemiology of Male Breast Cancer.

Authors:  Raina M Ferzoco; Kathryn J Ruddy
Journal:  Curr Oncol Rep       Date:  2016-01       Impact factor: 5.075

3.  Gene copy number variation in male breast cancer by aCGH.

Authors:  Stefania Tommasi; Anita Mangia; Giuseppina Iannelli; Patrizia Chiarappa; Elena Rossi; Laura Ottini; Marcella Mottolese; Wainer Zoli; Orsetta Zuffardi; Angelo Paradiso
Journal:  Cell Oncol (Dordr)       Date:  2011-05-06       Impact factor: 6.730

4.  The CHEK2*1100delC Mutation and Adolescent Breast Cancer: A Case Report of Breast Cancer in a 19-Year-Old and a Review of the Literature.

Authors:  Tahereh Soleimani; Abigail J Engwall; Corrie Bourdon; Mohammad A Torabi; Thais Fortes
Journal:  Breast Care (Basel)       Date:  2021-03-08       Impact factor: 2.860

5.  CHEK2*1100delC does not contribute to risk to breast cancer among Malay, Chinese and Indians in Malaysia.

Authors:  Eswary Thirthagiri; Leng San Cheong; Cheng Har Yip; Soo-Hwang Teo
Journal:  Fam Cancer       Date:  2009-04-28       Impact factor: 2.375

6.  Linkage disequilibrium mapping of CHEK2: common variation and breast cancer risk.

Authors:  Kristjana Einarsdóttir; Keith Humphreys; Carine Bonnard; Juni Palmgren; Mark M Iles; Arvid Sjölander; Yuqing Li; Kee Seng Chia; Edison T Liu; Per Hall; Jianjun Liu; Sara Wedrén
Journal:  PLoS Med       Date:  2006-05-09       Impact factor: 11.069

Review 7.  CHEK2 (∗) 1100delC Mutation and Risk of Prostate Cancer.

Authors:  Victoria Hale; Maren Weischer; Jong Y Park
Journal:  Prostate Cancer       Date:  2014-11-06

8.  The CHEK2 1100delC allelic variant is not present in familial and sporadic breast cancer cases from Moroccan population.

Authors:  Chaymaa Marouf; Omar Hajji; Brehima Diakité; Amal Tazzite; Hassan Jouhadi; Abdellatif Benider; Sellama Nadifi
Journal:  Springerplus       Date:  2015-02-01

9.  Association between CHEK2 H371Y mutation and response to neoadjuvant chemotherapy in women with breast cancer.

Authors:  Yin Liu; Ye Xu; Tao Ouyang; Jinfeng Li; Tianfeng Wang; Zhaoqing Fan; Tie Fan; Benyao Lin; Yuntao Xie
Journal:  BMC Cancer       Date:  2015-03-28       Impact factor: 4.430

10.  Inherited and acquired alterations in development of breast cancer.

Authors:  Piera Rizzolo; Valentina Silvestri; Mario Falchetti; Laura Ottini
Journal:  Appl Clin Genet       Date:  2011-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.